Gum Grafting Market: Growth Trends and Future Outlook

Gum Grafting Market

The Gum Grafting Market is anticipated to reach USD 794.22 Million by 2030 at 8.10% CAGR during the forecast period 2022-2030.



The Gum Grafting Market has witnessed significant growth in recent years, driven by the increasing prevalence of gum recession and the growing awareness of oral health. Gum grafting, also known as gum transplant or gum replacement, is a surgical procedure that involves taking tissue from one part of the mouth and grafting it onto the receding gums. This procedure is crucial for addressing issues such as gum recession, which can lead to tooth sensitivity, aesthetic concerns, and even tooth loss if left untreated.

The demand for gum grafting procedures has risen as people become more conscious of their oral health and seek effective solutions to restore gum tissue. Factors such as aging, genetics, and poor oral hygiene contribute to gum recession, making gum grafting an essential intervention. The market is witnessing advancements in grafting techniques and materials, enhancing the efficacy and patient experience.

The gum grafting market is also driven by the increasing prevalence of periodontal diseases, which often result in gum recession. The rising adoption of cosmetic dentistry procedures to improve the aesthetics of the smile further contributes to the market's growth. As technology continues to play a vital role in dental procedures, the gum grafting market is poised for continuous expansion, providing innovative solutions for individuals seeking gum replacement and restoration.Top of Form

Top of Form

Major Key Players:

This Key Gum Grafting Market Players are namely BioHorizons IPH, Inc (UK), Dr. Fresh LLC (US), Colgate-Palmolive Company (US), GlaxoSmithKline plc (UK), 3M Company (US), Ultradent Products Inc. (US), Sunstar Suisse S.A. (UK), and PatientPop.Inc (US).

Segment Analysis

The global gum grafting market is segmented on the basis of applications, types, end users and regions.

On the basis of applications, the market subsegments into  root coverage, ridge augmentation, augmentation around implants, reduced sensitivity, improved appearance, gum health, and others.

On the basis of types, the market is classified into connective-tissue, subepithelial connective tissue graft, free gingival grafts, pedicle grafts, and Alloderm.

On the basis of end users, the market is categorized into dentists, hospitals, and others.

Regional Analysis

The global gum grafting market is dominated by America, owing to the presence of a huge number of patients here, who are suffering from dental problems and the huge geriatric population. According to the Centers for Disease Control and Prevention, one out of every two American adults aged 30 years and over, has periodontal disease. In addition to this, high healthcare spending and presence of some of the major players in this region, has also contributed to the growth of this market. Europe accounts for the second largest market, as people here are being encouraged for dental surgeries and the  well-established healthcare sector. Asia Pacific is the fastest growing market, due to the presence of a number of growth opportunities here and continuously increasing demand. On the other hand, Middle East & Africa has the least market share.

The global gum grafting market is highly fragmented with the presence of many local and international players. Local players are focused on cost reduction and innovation to ensure sustainability. In addition, international players implemented growth strategies through collaborations and partnerships, to expand their overall market share.

BioHorizons IPH, Inc., headquartered in Birmingham, UK, is a manufacturer and supplier of introduced dental implant products’ covering, virtually every surgical and prosthetic indication or clinician preference. This company has launched Tapered Internal Implant, which was designed with a beveled collar for increased bone and soft tissue attachment and to provide benefits of platform switching. AlloDerm, Regenerative Tissue Matrix (RTM), is the most widely accepted and researched acellular dermal matrix for dental soft tissue applications.

For More Information, Please Visit @ Market Research Future

Comments

Post a Comment

Popular posts from this blog

Precision Medicine: Tailoring Healthcare for Individual Needs

  In recent years, the healthcare industry has witnessed a paradigm shift with the advent of personalized medicine, a groundbreaking approach that tailors medical treatment to the individual characteristics of each patient. The US, at the forefront of medical innovation, has embraced personalized medicine, leveraging advancements in genomic medicine, precision medicine, and personalized healthcare to revolutionize patient care. Precision medicine , also known as personalized medicine, represents a departure from the traditional one-size-fits-all approach to healthcare. Instead of treating patients based on generalized guidelines, precision medicine takes into account individual genetic makeup, lifestyle factors, and environmental influences to devise targeted treatment plans. This approach has the potential to optimize therapeutic outcomes, minimize adverse reactions, and improve overall patient satisfaction. At the heart of personalized medicine lies  genomic medicine , a fie...
Read more

Streamlining Success: Biopharmaceutical Contract Manufacturing Solutions

  In the ever-evolving landscape of healthcare, contract manufacturing has emerged as a pivotal force driving innovation and efficiency across various sectors, including biopharmaceuticals and medical devices. The healthcare contract manufacturing market plays a crucial role in enabling companies to focus on core competencies while leveraging specialized expertise and resources for the production of pharmaceuticals, medical devices, and equipment. With a growing demand for advanced therapies and medical technologies, the market is witnessing robust growth, propelled by factors such as outsourcing strategies, technological advancements, and regulatory complexities. Biopharmaceutical Contract Manufacturing: Biopharmaceutical contract manufacturing  involves the outsourcing of the production of biologic drugs, vaccines, and other therapeutic proteins to specialized manufacturers. This segment of the healthcare contract manufacturing market has experienced significant expansion in...
Read more

Exploring Effective Treatments for Peripheral Neuropathy: A Comprehensive Guide

  Peripheral neuropathy, a condition affecting millions worldwide, has spurred significant advancements in its treatment landscape. From traditional therapies to cutting-edge interventions, the peripheral neuropathy treatment market continues to evolve rapidly. Let's delve into the dynamics, innovations, and future prospects of this burgeoning market. Peripheral neuropathy  is characterized by damage to the peripheral nerves, leading to symptoms like numbness, tingling, and pain, often affecting the hands and feet. Its causes are diverse, including diabetes, autoimmune disorders, infections, and exposure to toxins. As the prevalence of conditions such as diabetes rises globally, the demand for effective neuropathy treatment escalates. One of the primary drivers propelling the  peripheral neuropathy treatment  market forward is the increasing focus on innovation. Pharmaceutical companies and research institutions are investing heavily in developing novel therapeutics ...
Read more